Noninvasive Detection of BCL2, BCL6, and MYC Translocations in Diffuse Large B-Cell Lymphoma

被引：10

作者：

Kurtz, David M. ^{[1
,2
]}

Scherer, Florian ^{[2
]}

Newman, Aaron M. ^{[3
]}

Craig, Alexander ^{[2
]}

Jin, Michael ^{[4
]}

Stehr, Henning ^{[2
]}

Chabon, Jacob J. ^{[5
]}

Esfahani, Mohammad ^{[6
]}

Liu, Chih Long ^{[6
]}

Zhou, Li ^{[2
]}

Glover, Cynthia ^{[2
]}

Visser, Brendan C. ^{[7
]}

Poultsides, George ^{[7
]}

Advani, Ranjana H. ^{[8
]}

Maeda, Lauren S. ^{[2
]}

Gupta, Neel K. ^{[2
]}

Levy, Ronald ^{[9
]}

Ohgami, Robert S. ^{[10
]}

Davis, R. Eric ^{[11
]}

Kunder, Christian A. ^{[10
]}

Westin, Jason R. ^{[12
]}

Diehn, Maximilian ^{[8
]}

Alizadeh, Ash A. ^{[2
]}

机构：

[1] Stanford Univ, Med Ctr, Dept Bioengn, Stanford, CA USA

[2] Stanford Univ, Med Ctr, Dept Med, Div Hematol & Oncol, Stanford, CA USA

[3] Stanford Univ, Div Oncol, Dept Med, Stanford, CA USA

[4] Stanford Univ, Stanford, CA USA

[5] Stanford Univ, Inst Stem Cell Biol, Stanford, CA USA

[6] Stanford Univ, Dept Med, Stanford, CA USA

[7] Stanford Univ, Med Ctr, Dept Surg, Stanford, CA USA

[8] Stanford Univ, Med Ctr, Stanford Canc Inst, Stanford, CA USA

[9] Stanford Univ, Sch Med, Stanford, CA USA

[10] Stanford Univ, Dept Pathol, Med Ctr, Stanford, CA USA

[11] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX USA

[12] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX USA

来源：

BLOOD | 2016年 / 128卷 / 22期

关键词：

D O I：

10.1182/blood.V128.22.2930.2930

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2930

引用

页数：4

共 50 条

[41] Clinical Impact of MYC, BCL2, BCL6, and MALT1 Alterations in Diffuse Large B-Cell Lymphoma (DLBCL) in the Rituximab (R) Era
Valera, S.
Cardesa, T.
Climent, F.
Ramagosa, V.
Gonzalez, E.
Arenillas, L.
Serrano, S.
Mate, J. L.
Salamero, O.
Lopez-Guillermo, A.
Campo, E.
Colomo, L.
MODERN PATHOLOGY, 2010, 23 : 326A - 326A
[42] Clinical Impact of MYC, BCL2, BCL6, and MALT1 Alterations in Diffuse Large B-Cell Lymphoma (DLBCL) in the Rituximab (R) Era
Valera, S.
Cardesa, T.
Climent, F.
Romagosa, V.
Gonzalez, E.
Arenillas, L.
Serrano, S.
Mate, J. L.
Salamero, O.
Lopez-Guillermo, A.
Campo, E.
Colomo, L.
LABORATORY INVESTIGATION, 2010, 90 : 326A - 326A
[43] BCL2 mutations in diffuse large B-cell lymphoma
J M Schuetz
N A Johnson
R D Morin
D W Scott
K Tan
S Ben-Nierah
M Boyle
G W Slack
M A Marra
J M Connors
A R Brooks-Wilson
R D Gascoyne
Leukemia, 2012, 26 : 1383 - 1390
[44] Clinical Significance of MYC, BCL2 and BCL6 Rearrangement and Protein Expression in GCB and Non-GCB Type Diffuse Large B-Cell Lymphoma
Kawamoto, Keisuke
Takizawa, Jun
Miyoshi, Hiroaki
Yoshida, Noriaki
Shibasaki, Yasuhiko
Masuko, Masayoshi
Sone, Hirohito
Nakamura, Naoya
Ohshima, Koichi
BLOOD, 2015, 126 (23)
[45] The Prognostic Value of MYC, BCL2 and BCL6 Translocations and Protein Expressions in Young Patients with High-Risk Diffuse Large B-Cell Lymphoma Treated with R-CHOEP
Pedersen, Mette Olgod
Gang, Anne Ortved
Hoegdall, Estrid
Knudsen, Helle
Lauritzen, Anne F.
Nielsen, Signe Ledou
Klausen, Tobias Wirenfeldt
Pedersen, Michael
Brown, Peter de Nully
Norgaard, Peter H.
BLOOD, 2014, 124 (21)
[46] Triple-Hit B-Cell Lymphomas With MYC, BCL2 and BCL6 Translocations: Morphological, Immunophenotypical, and Clinical Features
Wang, Wei
Hu, Shimin
Lu, Xinyan
Young, Ken
Medeiros, Jeffrey
MODERN PATHOLOGY, 2015, 28 : 384A - 384A
[47] Cutaneous involvement in a high grade B-cell lymphoma transformation of follicular lymphoma with rearrangement of MYC, BCL2 and BCL6
Martinez-Mera, Constanza
Camarero-Mulas, Celia
Herrero-Moyano, Maria
Chicharro, Pablo
Lopez-Elzaurdia, Consuelo
Renke, Andres Urquia
Aragues-Montanes, Maximiliano
Dauden-Tello, Esteban
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB89 - AB89
[48] DZNep-mediated apoptosis in B-cell lymphoma is independent of the lymphoma type, EZH2 mutation status and MYC, BCL2 or BCL6 translocations
Akpa, Chidimma Agatha
Kleo, Karsten
Lenze, Dido
Oker, Elisabeth
Dimitrova, Lora
Hummel, Michael
PLOS ONE, 2019, 14 (08):
[49] Prognostic Impact of Morphology, MYC Gene Partner and BCL2/BCL6 Translocation Status in "High Grade B-Cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements"
McPhail, Ellen D.
Maurer, Matthew J.
Ketterling, Rhett P.
Macon, William R.
Feldman, Andrew L.
Kurtin, Paul J.
Witzig, Thomas E.
Vaidya, Rakhee
Habermann, Thomas M.
BLOOD, 2016, 128 (22)
[50] Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes
Lue, Jennifer K.
Luttwak, Efrat
Rivas-Delgado, Alfredo
Irawan, Helen
Boardman, Alexander
Caron, Philip C.
David, Kevin
Epstein-Peterson, Zachary
Falchi, Lorenzo
Ghione, Paola
Hamlin, Paul
Horwitz, Steven M.
Intlekofer, Andrew M.
Johnson, William
Kumar, Anita
Moskowitz, Alison
Noy, Ariela
Palomba, M. Lia
Steiner, Ralphael
Stuver, Robert
Torka, Pallawi
Vardhana, Santosha
Zelenetz, Andrew D.
Schoder, Heiko
Imber, Brandon
Yahalom, Joachim
Zhang, Yanming
Galera, Pallavi
Dogan, Ahmet
Aypar, Umut
Salles, Gilles
BLOOD CANCER JOURNAL, 2024, 14 (01):

← 1 2 3 4 5 →